Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Evens

Showing results (131-140 of 253) with videos related to

Pageof 26
Sort By:
British Journal of Haematology|February 7, 2024
Patient preferences in the treatment of stage III/IV classic Hodgkin lymphoma: Results from the CONNECT cross-sectional surveyDarcy R Flora, Susan K Parsons, Nicholas Liu, et al.
JCO Oncology Practice|March 22, 2023
Observations of Oncologists on Treatment Selection With Interim Positron Emission Tomography-Adapted Approaches in Classic Hodgkin Lymphoma: The Real-World CONNECT StudySusan K Parsons, Kristina S Yu, Nicholas Liu, et al.
Leukemia & Lymphoma|August 22, 2012
Bortezomib may be safely combined with Y-90-ibritumomab tiuxetan in patients with relapsed/refractory follicular non-Hodgkin lymphoma: a phase I trial of combined induction therapy and bortezomib consolidationRupali Roy, Andrew M Evens, David Patton, et al.
Acta Obstetricia Et Gynecologica Scandinavica|February 1, 2024
Results of an international survey on the current organization of care for pregnant women with cancerJoosje H Heimovaara, Kristel van Calsteren, Christianne A R Lok, et al.
Blood Reviews|January 30, 2024
Harnessing multi-source data for individualized care in Hodgkin LymphomaSusan K Parsons, Angie Mae Rodday, Jenica N Upshaw, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 2, 2016
Allogeneic Hematopoietic Cell Transplantation as Curative Therapy for Patients with Non-Hodgkin Lymphoma: Increasingly Successful Application to Older PatientsTimothy S Fenske, Mehdi Hamadani, Jonathon B Cohen, et al.
Journal of Neuroinflammation|February 9, 2013
Cerebral ischemia initiates an immediate innate immune response in neonates during cardiac surgerySelma O Algra, Kathelijne M Groeneveld, Alvin W L Schadenberg, et al.
Scientific Reports|May 5, 2018
Author Correction: Role of hypoxia in Diffuse Large B-cell Lymphoma: Metabolic repression and selective translation of HK2 facilitates development of DLBCLKavita Bhalla, Sausan Jaber, Nanaji Nahid M, et al.
Scientific Reports|January 17, 2018
Role of hypoxia in Diffuse Large B-cell Lymphoma: Metabolic repression and selective translation of HK2 facilitates development of DLBCLKavita Bhalla, Sausan Jaber, Nanaji Nahid M, et al.
British Journal of Haematology|August 10, 2013
A phase I/II trial of bortezomib combined concurrently with gemcitabine for relapsed or refractory DLBCL and peripheral T-cell lymphomasAndrew M Evens, Steven T Rosen, Irene Helenowski, et al.
Pageof 26

Showing results (131-140 of 253) with videos related to

Sort By:
Pageof 26
British Journal of Haematology|February 7, 2024
Patient preferences in the treatment of stage III/IV classic Hodgkin lymphoma: Results from the CONNECT cross-sectional surveyDarcy R Flora, Susan K Parsons, Nicholas Liu, et al.
JCO Oncology Practice|March 22, 2023
Observations of Oncologists on Treatment Selection With Interim Positron Emission Tomography-Adapted Approaches in Classic Hodgkin Lymphoma: The Real-World CONNECT StudySusan K Parsons, Kristina S Yu, Nicholas Liu, et al.
Leukemia & Lymphoma|August 22, 2012
Bortezomib may be safely combined with Y-90-ibritumomab tiuxetan in patients with relapsed/refractory follicular non-Hodgkin lymphoma: a phase I trial of combined induction therapy and bortezomib consolidationRupali Roy, Andrew M Evens, David Patton, et al.
Acta Obstetricia Et Gynecologica Scandinavica|February 1, 2024
Results of an international survey on the current organization of care for pregnant women with cancerJoosje H Heimovaara, Kristel van Calsteren, Christianne A R Lok, et al.
Blood Reviews|January 30, 2024
Harnessing multi-source data for individualized care in Hodgkin LymphomaSusan K Parsons, Angie Mae Rodday, Jenica N Upshaw, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 2, 2016
Allogeneic Hematopoietic Cell Transplantation as Curative Therapy for Patients with Non-Hodgkin Lymphoma: Increasingly Successful Application to Older PatientsTimothy S Fenske, Mehdi Hamadani, Jonathon B Cohen, et al.
Journal of Neuroinflammation|February 9, 2013
Cerebral ischemia initiates an immediate innate immune response in neonates during cardiac surgerySelma O Algra, Kathelijne M Groeneveld, Alvin W L Schadenberg, et al.
Scientific Reports|May 5, 2018
Author Correction: Role of hypoxia in Diffuse Large B-cell Lymphoma: Metabolic repression and selective translation of HK2 facilitates development of DLBCLKavita Bhalla, Sausan Jaber, Nanaji Nahid M, et al.
Scientific Reports|January 17, 2018
Role of hypoxia in Diffuse Large B-cell Lymphoma: Metabolic repression and selective translation of HK2 facilitates development of DLBCLKavita Bhalla, Sausan Jaber, Nanaji Nahid M, et al.
British Journal of Haematology|August 10, 2013
A phase I/II trial of bortezomib combined concurrently with gemcitabine for relapsed or refractory DLBCL and peripheral T-cell lymphomasAndrew M Evens, Steven T Rosen, Irene Helenowski, et al.
Pageof 26